Last updated 2026-06-18
Total raised
—
Last: Undisclosed Round 2017-06
Stage
Mature
Founded
2016
Headcount
—
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
LogicBio Therapeutics develops gene therapy vectors for previously incurable genetic and infectious diseases, including hemophilia, HIV/AIDS, and methylmalonic acidemia. The company's proprietary technology is based on the nonpathogenic adeno-associated viral vector. The technology may offer improved efficiency and safety, and it is well suited for the treatment of both children and adults.
Offices
Ness Ziona, Israel · HQ / main office
Show all offices (1 more)
- Cambridge, United States
Q&A
- What is LogicBio Therapeutics' primary focus?
- LogicBio Therapeutics develops gene therapy vectors for previously incurable genetic and infectious diseases, including hemophilia, HIV/AIDS, and methylmalonic acidemia.
- What is the current status of LogicBio Therapeutics?
- LogicBio Therapeutics is currently inactive, having ceased operations in February 2019.
- When was LogicBio Therapeutics founded?
- LogicBio Therapeutics was founded in January 2016.
- How much capital has LogicBio Therapeutics raised in total?
- LogicBio Therapeutics has raised a total of $119,000,000.
- Who were the investors in LogicBio Therapeutics' June 2017 funding round?
- In June 2017, LogicBio Therapeutics received funding from SBI JI Innovation Fund and Pontifax.
- What is the employee count of LogicBio Therapeutics?
- LogicBio Therapeutics has an employee count in the 11-50 range.
- What technology does LogicBio Therapeutics' proprietary platform utilize?
- LogicBio Therapeutics' proprietary technology is based on the nonpathogenic adeno-associated viral vector.
- Where is LogicBio Therapeutics headquartered?
- LogicBio Therapeutics is headquartered in Ness Ziona, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
genome-editingdrug-discoverypharmaceuticalsrare-diseasesdrug-discoverydrug-discoveryrare-diseasescell-therapygenetic-disorders
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/11005499 |
Identifiers & details
| Founded | 2016-1 |
|---|---|
| Offices | Cambridge |
| Status reason | Non Active, Feb 2019 ceased to operate |